ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme
Clinical trial NCT04587830 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04587830
- Sponsor
- Polaris Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-14
- Primary completion
- 2027-02-28
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.